Guided Therapeutics, Inc. Financial Ratios — GTHP Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-161.48	-111.79	-212.39	-311.42	-248.9	-198.15	-1,127.08	316.51	-271.33	-22.06	-122.12	-160.6	-138.59	-158.65	-236.57
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	-2.13	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	97.07	96.57	48.18	-8.26	11.39	18.51	-117.21	-56.14	-94.44	140.2	24.69	-523.08	36.73	28.57	74.45
EBITDA Margin (%)	-185.59	-114.96	-521.37	-902.67	-853.63	-429.26	-1,191.8	-2,668.42	-2,544.44	-1,031.37	-2,813.58	-25,084.62	-3,440.82	-28,757.14	-295.31
Operating Margin (%)	-186.53	-125.54	-560.47	-1,053.34	-1,027.56	-631.4	-1,279.1	-2,715.79	-2,602.78	-1,031.37	-2,916.05	-25,638.46	-3,527.55	-30,114.29	-309.26
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-183.43	-127.65	-611.96	-1,200.85	-1,138.94	-656.2	-4,383.61	1,782.46	-5,336.11	-273.53	-2,555.56	-33,392.31	-3,560.2	-34,528.57	-416.69
Profit Margin (%)	-183.43	-127.65	-611.96	-1,200.85	-1,138.94	-656.2	-4,383.61	1,782.46	-5,336.11	-273.53	-2,555.56	-33,392.31	-3,560.2	-34,528.57	-416.69
Net Income to Common Margin (%)	-183.43	-127.65	-881.26	-1,219.32	-1,359.74	-825.62	-4,497.54	1,578.95	-5,336.11	-393.14	-3,001.23	-38,246.15	-3,734.69	-37,014.29	-436.25
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	30.56	1.51	16.24	20.52	2.53	-12.89	- -	30.42	14.85	12.69	4.67	6.72	4.48
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	1	- -	3	2	4	5	5	6	4	3	2	2	2	3
ST Debt	- -	1	- -	2	2	4	5	5	5	3	1	1	1	2	2
LT Debt	- -	- -	- -	1	- -	- -	- -	- -	1	1	2	1	1	- -	1
Total Debt/EBITDA	-0.06	-0.13	-0.04	-0.36	-0.29	-1.55	-1.6	-3.35	-6.57	-4.19	-1.27	-0.69	-0.58	-1.07	-1.3
Net Debt/EBITDA	0.26	0.14	0.06	-0.34	-0.29	-1.55	-1.6	-3.35	-5.45	-3.59	-0.82	0.11	-0.33	-0.8	-0.96
Total Debt/EBIT	-0.06	-0.12	-0.04	-0.31	-0.24	-1.06	-1.49	-3.29	-6.42	-4.19	-1.23	-0.68	-0.57	-1.02	-1.24
Net Debt/EBIT	0.26	0.13	0.06	-0.29	-0.24	-1.05	-1.49	-3.29	-5.32	-3.59	-0.79	0.11	-0.32	-0.77	-0.92
EBITDA to Interest Expense	-84.02	-54.44	-136.6	-7.59	-3.93	-1.37	-2.63	-0.86	-0.65	-1	-1.98	-5.6	-12.13	-5.28	-3.67
EBITDA-CapEx/Interest Expense	-89.58	-62.11	-138.98	-7.74	-3.93	-1.37	-2.63	-0.86	-0.65	-1	-1.99	-5.66	-12.13	-5.28	-3.67
EBIT to Interest Expense	-84.45	-59.46	-146.84	-8.85	-4.73	-2.02	-2.82	-0.88	-0.66	-1	-2.05	-5.73	-12.44	-5.53	-3.84
Interest Expense	- -	- -	- -	1	1	2	1	2	1	1	1	1	- -	- -	1
Common Equity/Total Assets	-1,973.02	-2,646.23	-3,104.76	-3,726.92	-4,863.9	-8,499.73	-33,926.6	-57,100.42	-11,539.07	-10,115.04	-6,812.94	-4,275.76	-8,848.23	-10,903.99	-11,600
Long-Term Debt/Equity (%)	0.25	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	-0.1	-0.75	- -	- -	- -	-0.26	-0.47	-0.78	-1.36	-0.99	-0.47	-0.08	-0.47
Long-Term Debt/Total Assets (%)	0.09	- -	3.11	27.15	- -	- -	- -	144.07	51.95	75.19	86.23	40.85	39.9	8.13	52.42
Total Debt/Equity (%)	26.7	44.31	-230.84	-59.44	-27.38	-43.54	-23.93	-32.21	-35.54	-40.58	-53.24	-78.49	-51.5	-44.16	-48.93
Total Debt/Capital (%)	-0.5	-0.55	-0.24	-2.42	-1.28	-3.32	-3.52	-3.96	-4.65	-3.4	-2.24	-1.63	-1.37	-1.49	-1.97
Total Debt/Total Assets (%)	9.77	14.43	7.45	87.56	60.56	270.38	1,143.35	2,159.75	510.08	326.3	142.11	67.23	117.44	156.68	221.98
Net Debt to Equity	-112.81	-47.84	342.06	-55.81	-26.75	-43.38	-23.92	-32.21	-29.45	-34.78	-34.23	13.01	-29.51	-33.05	-36.3
Net Debt/Capital (%)	2.05	0.59	0.36	-2.27	-1.25	-3.31	-3.51	-3.96	-3.83	-2.91	-1.44	0.27	-0.78	-1.11	-1.46
EBITDA	-7	-4	-6	-7	-5	-3	-3	-2	-1	-1	-2	-3	-3	-2	-2
EBITDA-CapEx	-7	-4	-6	-8	-5	-3	-3	-2	-1	-1	-2	-3	-3	-2	-2
Operating Income (Loss)	-7	-4	-7	-9	-6	-4	-3	-2	-1	-1	-2	-3	-3	-2	-2

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.81	0.45	0.35	0.04	0.01	- -	- -	- -	0.07	0.02	0.11	0.48	0.12	0.06	0.01
Current Ratio	1.06	0.8	1.15	0.39	0.39	0.11	0.03	0.02	0.08	0.1	0.29	0.62	0.29	0.19	0.09
Quick Ratio	0.85	0.49	0.42	0.11	0.04	- -	- -	- -	0.07	0.02	0.12	0.48	0.12	0.06	0.01
CFO/Avg Current Liab	-0.99	-1.45	-2.7	-1.97	-0.8	-0.24	-0.11	-0.12	-0.07	-0.18	-0.22	-0.28	-0.36	-0.2	-0.17
Common Equity/Total Assets	-1,973.02	-2,646.23	-3,104.76	-3,726.92	-4,863.9	-8,499.73	-33,926.6	-57,100.42	-11,539.07	-10,115.04	-6,812.94	-4,275.76	-8,848.23	-10,903.99	-11,600
Long-Term Debt/Equity (%)	0.25	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	-0.1	-0.75	- -	- -	- -	-0.26	-0.47	-0.78	-1.36	-0.99	-0.47	-0.08	-0.47
Long-Term Debt/Total Assets (%)	0.09	- -	3.11	27.15	- -	- -	- -	144.07	51.95	75.19	86.23	40.85	39.9	8.13	52.42
Total Debt/Equity (%)	26.7	44.31	-230.84	-59.44	-27.38	-43.54	-23.93	-32.21	-35.54	-40.58	-53.24	-78.49	-51.5	-44.16	-48.93
Total Debt/Capital (%)	-0.5	-0.55	-0.24	-2.42	-1.28	-3.32	-3.52	-3.96	-4.65	-3.4	-2.24	-1.63	-1.37	-1.49	-1.97
Total Debt/Total Assets (%)	9.77	14.43	7.45	87.56	60.56	270.38	1,143.35	2,159.75	510.08	326.3	142.11	67.23	117.44	156.68	221.98
CFO/Total Liabilities	-100.04	-156.33	-162.31	-83.82	-50.06	-16.75	-5.78	-8.5	-4.45	-15.36	-21.27	-23.67	-31.89	-17.86	-14.57
CFO/CapEx	-6.16	-6.64	-51.93	-41.89	-505.38	- -	- -	- -	- -	-1,875	-113.71	-47.71	- -	- -	-534
Altman's Z-Score	-31.93	-40.32	-49.62	-62.51	-77.75	-134.41	-536.6	-892.77	-179.74	-154.81	-103.26	-64.28	-135.13	-164.7	-176.87

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	35.86	30.45	9.82	3.49	2.3	6.37	162.67	7.12	2.77	5.51	2.31	0.5	15.08	1.4	219.14
Days Sales Outstanding	10.18	11.99	37.15	104.44	159.01	57.31	2.24	51.23	131.81	66.2	157.72	730	24.21	260.71	1.67
Inventory Turnover	0.41	0.22	0.71	0.75	0.47	0.52	1.11	0.6	0.86	-0.13	0.1	0.14	0.11	0.01	0.36
Days Inventory Outstanding	895.28	1,628.46	512.85	486.05	781.32	700.39	328.84	606.97	422.36	-2,906.65	3,518.36	2,521.2	3,473.39	46,172.5	1,006.54
Accounts Payable Turnover	0.62	0.13	1.55	0.67	0.27	0.07	-0.02	0.01	- -	0.19	0.01	0.02	0.07	- -	- -
Accounts Payable Turnover Days	588.02	2,815.93	236.11	545.42	1,363.77	5,492.38	-16,810.94	52,420.95	275,848.75	1,969.3	33,688.15	14,706.98	5,310	126,320.42	75,936.59
Cash Conversion Cycle	317.44	-1,175.48	313.89	45.07	-423.44	-4,734.68	17,142.03	-51,762.76	-275,294.59	-4,809.75	-30,012.07	-11,455.78	-1,812.4	-79,887.2	-74,928.38
Inventory to Cash Days	-885.1	-1,616.47	-475.7	-381.61	-622.31	-643.07	-326.6	-555.74	-290.55	2,972.85	-3,360.64	-1,791.2	-3,449.18	-45,911.79	-1,004.88
Inventories	1	1	1	1	1	1	- -	- -	- -	1	1	1	1	1	- -
Raw Materials	- -	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8	10	8	9	- -
- Cash & Cash Equivalents	2	1	1	- -	- -	- -	- -	- -	1	- -	1	2	1	- -	- -
+ Preferred Equity and Hybrid Capital	- -	- -	1	1	2	1	1	1	1	3	7	3	3	3	2
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	1	- -	3	2	4	5	5	6	4	3	2	2	2	3
Enterprise Value	-2	-1	1	3	4	5	6	6	6	7	17	13	12	13	4
Total Capital	-85	-92	-102	-110	-119	-121	-132	-129	-129	-129	-129	-139	-143	-145	-149
Total Debt/Capital (%)	-0.5	-0.55	-0.24	-2.42	-1.28	-3.32	-3.52	-3.96	-4.65	-3.4	-2.24	-1.63	-1.37	-1.49	-1.97
Total Debt / EV	-0.25	-0.93	0.32	0.84	0.43	0.76	0.81	0.86	1.02	0.63	0.17	0.18	0.16	0.16	0.65
EV/Sales	26.4	12.6	0.66	3.85	5.84	8.8	23.35	103.56	164.61	68.08	208.45	983.27	124.87	1,910.12	5.86
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	57.23	- -	14.83	9.78	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	57.23	- -	14.83	9.78	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8	10	8	9	- -
Diluted Enterprise Value	-2	-1	1	3	4	5	6	6	6	7	17	13	12	13	4
EV per Share	95,605,000	42,978,000	773,000	1,585,000	1,180,000	6,366.03	517.91	12.78	1.79	0.64	1.26	0.39	0.24	0.23	- -
TTM Sales	4	3	1	1	1	1	- -	- -	- -	- -	- -	- -	- -	- -	1
TTM EBITDA	-7	-4	-6	-7	-5	-3	-3	-2	-1	-1	-2	-3	-3	-2	-2
TTM Operating Income	-7	-4	-7	-9	-6	-4	-3	-2	-1	-1	-2	-3	-3	-2	-2
TTM Cash Flow to Firm	-3	-4	-6	-5	-3	- -	- -	- -	1	-1	- -	-1	-1	-1	- -
TTM Free Cash Flow to Firm	-2	-3	-5	-5	-3	- -	- -	- -	1	-1	- -	-1	-1	-1	- -

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-4.92	-6.73	-4.5	-7.69	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-2	-1	1	3	4	5	6	6	6	7	17	13	12	13	4
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.09	0.23	0.06	0.06	0.06
EV/Sales	26.4	12.6	0.66	3.85	5.84	8.8	23.35	103.56	164.61	68.08	208.45	983.27	124.87	1,910.12	5.86
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-3.47	-3.28	-2.85	-3.09	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-5.5	-5.1	-5.17	-5.09	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.47	-1.47	-0.87	-1.42	- -
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.06	-0.07	-0.05	-0.06	- -
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.06	-0.11	-0.07	-0.05	- -
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.1	-0.18	-0.13	-0.09	- -
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.01	-0.05	-0.02	-0.02	- -
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.63	-1.64	-1.15	-1.09	- -
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.68	-2.74	-1.53	-1.02	- -
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1.09	-4.25	-2.77	-1.67	- -
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.09	-1.23	-0.46	-0.47	- -
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	95.79	750.12	80.09	1,228.69	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	104.01	1,256.03	106.29	1,145.16	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	165.15	1,950.05	193.05	1,884	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.05	562.84	32.35	524.24	- -
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-4.87	-6.59	-4.5	-7.69	- -
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-5.29	-11.04	-5.97	-7.16	- -
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-8.4	-17.14	-10.84	-11.79	- -
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.72	-4.95	-1.82	-3.28	- -
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-5.34	-11.28	-5.97	-7.16	- -
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-8.48	-17.51	-10.84	-11.79	- -
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.72	-5.05	-1.82	-3.28	- -
EV/Sales Average	16.74	14.71	0.66	3.85	5.84	8.8	23.35	103.56	164.61	68.08	216.68	1,489.18	151.07	1,826.59	5.86
EV/Sales High	26.75	34.37	0.66	3.85	5.84	8.8	23.35	103.56	164.61	68.08	277.81	2,183.2	237.83	2,565.42	5.86
EV/Sales Low	11.02	7.91	0.66	3.85	5.84	8.8	23.35	103.56	164.61	68.08	126.72	795.99	77.13	1,205.67	5.86
EV/EBITDA Average	0.25	0.14	-0.13	-0.43	-0.68	-2.05	-1.96	-3.88	-6.47	-6.6	-7.7	-5.94	-4.39	-6.35	-1.98
EV/EBITDA High	0.25	0.14	-0.13	-0.43	-0.68	-2.05	-1.96	-3.88	-6.47	-6.6	-9.87	-8.7	-6.91	-8.92	-1.98
EV/EBITDA Low	0.25	0.14	-0.13	-0.43	-0.68	-2.05	-1.96	-3.88	-6.47	-6.6	-4.5	-3.17	-2.24	-4.19	-1.98
EV/EBIT Average	0.25	0.13	-0.12	-0.37	-0.57	-1.39	-1.83	-3.81	-6.32	-6.6	-7.43	-5.81	-4.28	-6.07	-1.89
EV/EBIT High	0.25	0.13	-0.12	-0.37	-0.57	-1.39	-1.83	-3.81	-6.32	-6.6	-9.53	-8.52	-6.74	-8.52	-1.89
EV/EBIT Low	0.25	0.13	-0.12	-0.37	-0.57	-1.39	-1.83	-3.81	-6.32	-6.6	-4.35	-3.1	-2.19	-4	-1.89
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.58	0.3	0.15	0.15	0.54
High Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	0.78	0.37	0.23	0.54
Enterprise Value Average	-2	-1	1	3	4	5	6	6	6	7	18	19	15	13	4
Enterprise Value High	-2	-1	1	3	4	5	6	6	6	7	23	28	23	18	4
Enterprise Value Low	-2	-1	1	3	4	5	6	6	6	7	10	10	8	8	4

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	3	3	13	14	49	54	65	86
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	65	3	11	13	33	51	57	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	3	11	13	33	51	57	- -
Revenue per Share	3,622,000	3,410,000	1,179,000	411,500	202,000	723.68	22.18	0.12	0.01	0.01	0.01	- -	- -	- -	- -
EBITDA per Share	-6,722,000	-3,920,000	-6,147,000	-3,714,500	-1,724,333.33	-3,106.46	-264.36	-3.29	-0.28	-0.1	-0.17	-0.1	-0.07	-0.04	- -
Operating Income per Share	-6,756,000	-4,281,000	-6,608,000	-4,334,500	-2,075,666.67	-4,569.38	-283.73	-3.35	-0.28	-0.1	-0.18	-0.1	-0.07	-0.04	- -
Basic EPS, GAAP	-6,644,000	-4,353,000	-10,390,000	-5,017,500	-2,746,666.67	-5,974.88	-997.64	1.95	-0.58	-0.04	-0.18	-0.15	-0.07	-0.05	- -
Basic EPS from Cont Ops	-6,644,000	-4,353,000	-7,215,000	-4,941,500	-2,300,666.67	-4,748.8	-972.36	2.2	-0.58	-0.03	-0.15	-0.13	-0.07	-0.04	- -
Diluted EPS, GAAP	-6,644,000	-4,353,000	-10,390,000	-5,017,500	-2,746,666.67	-5,974.88	-997.64	0.01	-0.58	-0.04	-0.18	-0.15	-0.07	-0.05	- -
Diluted EPS from Cont Ops	-6,644,000	-4,353,000	-7,215,000	-4,941,500	-2,300,666.67	-4,748.8	-972.36	0.02	-0.58	-0.03	-0.15	-0.13	-0.07	-0.04	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-2,734,000	-3,666,000	-5,556,000	-3,141,500	-1,347,666.67	-2,155.5	-104	-2.95	-0.24	-0.17	-0.12	-0.05	-0.03	-0.02	- -
Free Cash Flow per Basic Share	-3,178,000	-4,218,000	-5,663,000	-3,216,500	-1,350,333.33	-2,155.5	-104	-2.95	-0.24	-0.17	-0.12	-0.05	-0.03	-0.02	- -
Cash & Equivalents per Share	2,200,000	1,044,000	613,000	81,000	11,666.67	16.75	0.09	- -	0.27	0.02	0.05	0.07	0.01	0.01	- -
Book Value per Share	-85,037,000	-92,036,000	-102,954,000	-56,481,500	-40,775,666.67	-151,693.78	-12,522	-291.68	-41.24	-12.68	-10.39	-4.43	-2.89	-2.62	- -
Tangible Book Value per Share	1,577,000	1,133,000	-1,246,000	-2,571,500	-2,538,000	-12,641.15	-1,859.82	-36	-5.37	-1.26	-0.92	-0.18	-0.13	-0.14	- -

Guided Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)